Cross–reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen

Abstract
Summary Monoclonal antibodies directed against the 51 kD merozoite surface antigen of Plasmodium falciparum also bind to other antigens within the infected cell. The sizes of these cross–reacting antigens have been characterized. Immunofluorescence due to the reaction of one of the monoclonal antibodies with these cross–reacting antigens was localized in the intra–erythrocytic parasite and in granules in the infected red cell cytoplasm. This immunofluorescence could be distinguished from the merozoite surface antigen in parasite lines with a variant serotype of the merozoite surface antigen which fails to react with the monoclonal antibodies. It was found that the in–vitro growth inhibition caused by the presence of one of the monoclonal antibodies, 8G10/48, was dependent on the expression of the corresponding serotype of merozoite surface antigen, a finding consistent with the inhibitory effect of this antibody being primarily directed against the merozoite surface antigen and not the cross–reacting antigens. Analysis of the frequency at which epitopes occur suggests that such cross–reacting proteins will be commonly seen in malaria, without the need to postulate a selective advantage for such cross–reacting specificities.